VelosBio is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.
Business Model:
Revenue: $2.5M
Employees: 11-50
VelosBio was acquired by
Merck Sharp &a; Dohme Sweden AB.
The acquisition happend on 2020-11-05.
Details of the transaction were not public
Address: 11045 Roselle Street
City: San Diego
State: CA
Zip: 92121
Country: US
VelosBio is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.
Contact Phone:
+18584616666
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2018 | Seed Round | $7.7M | 9/2018 | Series A | $59.3M |
Arix Bioscience plc Sofinnova Ventures Pappas Ventures Chiesi Ventures Takeda Ventures, Inc Decheng Capital |
7/2018 | Debt | $6.5M | 7/2020 | Series B | 18 | $137M |
Arix Bioscience Viking Global Investors Pappas Capital Farallon Capital Management Janus Henderson Investors Foresite Capital Sofinnova Investments T. Rowe Price Cormorant Asset Management Venrock Matrix Capital Management Surveyor Capital Wellington Management Takeda Ventures OrbiMed Viking Global Investors Pappas Capital Farallon Capital Management Janus Henderson Investors Foresite Capital Arix Bioscience Sofinnova Investments T. Rowe Price Cormorant Asset Management Venrock Matrix Capital Management Surveyor Capital |
10/2018 | Series A | 6 | $58M |
Arix Bioscience Chiesi Ventures Decheng Capital Pappas Ventures Sofinnova Investments Takeda Ventures Arix Bioscience |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|